Literature DB >> 30379386

Economic evaluation of a healthy lifestyle intervention for chronic low back pain: A randomized controlled trial.

Amanda Williams1,2,3, Johanna M van Dongen4,5, Steven J Kamper3,6, Kate M O'Brien1,2,3, Luke Wolfenden1,2, Sze L Yoong1,2, Rebecca K Hodder1,2,3, Hopin Lee1,3,7,8, Emma K Robson1,2,3, Robin Haskins9, Chris Rissel10, John Wiggers1,2, Christopher M Williams1,2,3.   

Abstract

BACKGROUND: Economic evaluations which estimate cost-effectiveness of potential treatments can guide decisions about real-world healthcare services. We performed an economic evaluation of a healthy lifestyle intervention targeting weight loss, physical activity and diet for patients with chronic low back pain, who are overweight or obese.
METHODS: Eligible patients with chronic low back pain (n = 160) were randomized to an intervention or usual care control group. The intervention included brief advice, a clinical consultation and referral to a 6-month telephone-based healthy lifestyle coaching service. The primary outcome was quality-adjusted life years (QALYs). Secondary outcomes were pain intensity, disability, weight and body mass index. Costs included intervention costs, healthcare utilization costs and work absenteeism costs. An economic analysis was performed from the societal perspective.
RESULTS: Mean total costs were lower in the intervention group than the control group (-$614; 95%CI: -3133 to 255). The intervention group had significantly lower healthcare costs (-$292; 95%CI: -872 to -33), medication costs (-$30; 95%CI: -65 to -4) and absenteeism costs (-$1,000; 95%CI: -3573 to -210). For all outcomes, the intervention was on average less expensive and more effective than usual care, and the probability of the intervention being cost-effective compared to usual care was relatively high (i.e., 0.81) at a willingness-to-pay of $0/unit of effect. However, the probability of cost-effectiveness was not as favourable among sensitivity analyses.
CONCLUSIONS: The healthy lifestyle intervention seems to be cost-effective from the societal perspective. However, variability in the sensitivity analyses indicates caution is needed when interpreting these findings. SIGNIFICANCE: This is an economic evaluation of a randomized controlled trial of a healthy lifestyle intervention for chronic low back pain. The findings suggest that a healthy lifestyle intervention may be cost-effective relative to usual care.
© 2018 European Pain Federation - EFIC®.

Entities:  

Mesh:

Year:  2018        PMID: 30379386     DOI: 10.1002/ejp.1334

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  5 in total

1.  Fear-avoidance beliefs, anxiety and depression are associated with motor control and dynamics parameters in patients with chronic low back pain.

Authors:  Yannick Delpierre
Journal:  J Orthop       Date:  2022-01-23

2.  Healthy Lifestyle Program (HeLP) for low back pain: protocol for a randomised controlled trial.

Authors:  Emma K Robson; Steven J Kamper; Simon Davidson; Priscilla Viana da Silva; Amanda Williams; Rebecca K Hodder; Hopin Lee; Alix Hall; Connor Gleadhill; Christopher M Williams
Journal:  BMJ Open       Date:  2019-09-03       Impact factor: 2.692

3.  A mixed-methods study to evaluate the effectiveness and cost-effectiveness of aerobic exercise for primary dysmenorrhea: A study protocol.

Authors:  Priya Kannan; Kwok-Kuen Cheung; Benson Wui-Man Lau; Lin Li; Huijun Chen; Fenghua Sun
Journal:  PLoS One       Date:  2021-08-16       Impact factor: 3.240

Review 4.  Lifestyle Medicine for Chronic Lower Back Pain: An Evidence-Based Approach.

Authors:  Ziya Altug
Journal:  Am J Lifestyle Med       Date:  2021-07-21

5.  Cost-effectiveness analysis of a chronic back pain multidisciplinary biopsychosocial rehabilitation (MBR) compared to standard care for privately insured in Germany.

Authors:  M Hochheim; P Ramm; M Wunderlich; V Amelung
Journal:  BMC Health Serv Res       Date:  2021-12-24       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.